A new initiative by the Food and Drug Administration (FDA) to expedite drug review timelines has raised significant concerns among agency staff and external experts. Critics...
A group of twelve former leaders of the U.S. Food and Drug Administration (FDA) has issued a strong condemnation of recent statements made by the agency...
Eli Lilly has announced a reduction in the price of its obesity treatment, Zepbound, to enhance affordability for U.S. patients. Starting immediately, patients with a prescription...
Eli Lilly has announced a significant reduction in the prices of its obesity treatment, Zepbound, aiming to increase accessibility for U.S. patients. As of March 2024,...
Understanding the process of selecting candidates for clinical research trials is crucial for ensuring participant safety and ethical standards. Clinical trials are governed by strict regulations...
The introduction of cloned meats into international markets has sparked significant concern regarding their quality and the potential impact on traditional farmers. As cloned products gain...
Unapproved peptide injections have surged in popularity, championed by wellness influencers, fitness coaches, and celebrities as a means to enhance muscle growth, promote weight loss, and...
The U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to Elanco Animal Health for its product Credelio (lotilaner), designed to treat infections...
AbbVie, a global biopharmaceutical company, has announced the launch of its ovarian cancer therapy, Elahere, in the United Kingdom. The treatment will be priced at the...
American Diversified Holdings Corporation (ADHC) has announced significant advancements in the development of its innovative GlucoGuard system, following a detailed update from its partner, Arete Biosciences,...
